» Articles » PMID: 33491080

Association of Longitudinal Changes in NT-proBNP With Changes in Left Atrial Volume and Function: MESA

Overview
Journal Am J Hypertens
Date 2021 Jan 25
PMID 33491080
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The mechanism of left atrial (LA) remodeling is poorly understood. The aim of this longitudinal study was to investigate whether changes in NT-proBNP levels relate to alterations of LA structure and function over time in a multiethnic population.

Methods: From the prospective cohort study, the Multi-Ethnic Study of Atherosclerosis, our analysis included 1,838 participants who underwent cardiac magnetic resonance imaging at the baseline and 10-year examinations, had NT-proBNP levels available at both time points, and did not develop heart failure, myocardial infarction, and/or atrial fibrillation. Multivariable linear regression was used to analyze the association between NT-proBNP level (log-transformed) at the 2 time points and change in LA volumes, LA emptying fractions (total, active, and passive), and LA longitudinal strain. Log NT-proBNP was categorized into Low-Low (N = 681), Low-High (N = 238), High-Low (N = 237), and High-High (N = 682) based on the median value at both time points.

Results: With the Low-Low group as the reference group, the High-High group experienced a greater increase in LA maximum and minimum indexed volumes: 3.1 ml/m2 (95% confidence interval 1.98, 4.20) and 2.7 ml/m2 (1.89, 3.51), respectively. The High-High group also experienced a greater decrease in LA total, passive, active emptying fraction, and longitudinal strain: -3.3% (-4.46, -2.11), -0.9% (-1.80, -0.02), -4.2% (-5.55, -2.76), and -2.3% (-3.80, -0.72), respectively. The Low-High group had similar associations, but the effect sizes were not as high.

Conclusions: Adverse LA remodeling over 10 years of follow-up strongly correlates with prolonged elevated levels of intracardiac stress, as assessed by NT-proBNP levels.

Citing Articles

The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease.

Mouzarou A, Hadjigeorgiou N, Melanarkiti D, Plakomyti T Diagnostics (Basel). 2025; 15(1.

PMID: 39795641 PMC: 11719755. DOI: 10.3390/diagnostics15010113.


Atrial Strain and Strain Rate in a General Population: Do These Measures Improve the Assessment of Elevated NT-proBNP Levels?.

Rosner A, Kornev M, Caglayan H, Queiros S, Malyutina S, Ryabikov A Cardiol Res Pract. 2024; 2024:1546629.

PMID: 39224177 PMC: 11368553. DOI: 10.1155/2024/1546629.


Predictive value of NT pro BNP for new-onset atrial fibrillation in heart failure and preserved ejection fraction.

Liu X, Chen S, Pan H, Zhang Z, Wang Y, Jiang Y ESC Heart Fail. 2024; 11(6):4296-4307.

PMID: 39193834 PMC: 11631295. DOI: 10.1002/ehf2.14951.


Improved Interpretation of Pulmonary Artery Wedge Pressures through Left Atrial Volumetry-A Cardiac Magnetic Resonance Imaging Study.

Guder G, Reiter T, Drayss M, Bauer W, Lengenfelder B, Nordbeck P J Cardiovasc Dev Dis. 2024; 11(6).

PMID: 38921678 PMC: 11204227. DOI: 10.3390/jcdd11060178.


The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV.

Jacobsen M, Jensen A, Knudsen A, Benfield T, Frikke-Schmidt R, Nordestgaard B J Obes. 2023; 2023:6199388.

PMID: 38026824 PMC: 10640655. DOI: 10.1155/2023/6199388.


References
1.
Karam B, Chavez-Moreno A, Koh W, Akar J, Akar F . Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017; 16(1):120. PMC: 5622555. DOI: 10.1186/s12933-017-0604-9. View

2.
Heckbert S, Wiggins K, Blackshear C, Yang Y, Ding J, Liu J . Pericardial fat volume and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis and Jackson Heart Study. Obesity (Silver Spring). 2017; 25(6):1115-1121. PMC: 5445011. DOI: 10.1002/oby.21835. View

3.
Aljizeeri A, Gin K, Barnes M, Lee P, Nair P, Jue J . Atrial remodeling in newly diagnosed drug-naive hypertensive subjects. Echocardiography. 2013; 30(6):627-33. DOI: 10.1111/echo.12119. View

4.
Patton K, Heckbert S, Alonso A, Bahrami H, Lima J, Burke G . N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity. Heart. 2013; 99(24):1832-6. DOI: 10.1136/heartjnl-2013-304724. View

5.
Potter L . Natriuretic peptide metabolism, clearance and degradation. FEBS J. 2011; 278(11):1808-17. PMC: 4495883. DOI: 10.1111/j.1742-4658.2011.08082.x. View